Companies: 10,795·Total market cap: $144.5T
Extendicare Inc.

Extendicare Inc.

EXE.TOTSXHealthcare● Active
$33.14
+$1.07(+3.34%)
Market Cap$3.1B
P/E Ratio
52W High$35.62
52W Low$12.12

Extendicare Inc. (EXE.TO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

EXE.TO · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $96.7M for FY2025 (fiscal year ending 2025-12-31), up 28.5% year-over-year. Net profit margin was 5.8%. Based on available data, Extendicare Inc. has been profitable since at least 2012.

FY2025 Net Income$96.7M▲ +28.5% YoY
Trailing 12M (TTM)$122.4Mtrailing 4 quarters sum
Net Profit Margin5.8%$96.7M ÷ $1.66B
YoY Change+28.5%
5-Year CAGR+12.3%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2012

▸ FMP /income-statement · Annual · EXE.TO net income history · EXE.TO profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$96.7M▲ +28.5%5.8%
FY2024$75.2M▲ +121.3%5.1%
FY2023$34.0M▼ 51.1%2.6%
FY2022$69.6M▲ +504.6%5.7%
FY2021$11.5M▼ 78.8%1.0%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Extendicare Inc.
Extendicare Inc.YOU
EXE.TO
$96.7M+28.5%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Extendicare Inc. (EXE.TO) reported net income of $96.7M for FY2025 (fiscal year ending 2025-12-31), up 28.5% year-over-year. The net profit margin was 5.8% — meaning the company kept $0.06 of every dollar of revenue as profit.

Based on available data, Extendicare Inc. has been profitable since at least 2012. Net income reached a peak of $232.1M in FY2015. Data available for 15 fiscal years.

Extendicare Inc.'s net profit margin was 5.8% for FY2025, based on the latest annual results.

Investors sometimes search for "Extendicare Inc. net worth" — the company's market capitalization is a separate figure from EXE.TO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

EXE.TO net income · 5 questions

Extendicare Inc. is profitable. The company reported net income of $96.7M for FY2025, a net profit margin of 5.8%. Net income was up 28.5% year-over-year. Based on available data, Extendicare Inc. has been profitable since at least 2012.

is EXE.TO profitabledoes EXE.TO make a profitEXE.TO profitabilityEXE.TO profitable company

Source: FMP /income-statement · GAAP · Extendicare Inc. · Extendicare Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026